INFANRIX-HEXA MIN 30 I.U+MIN 40 I.U+25?G+25?G+8?G+10?G,40DU+8DU+32DU+10?G PARENTERAL ORDINARY COMBINATION PACK VIALS

Nazione: Uganda

Lingua: inglese

Fonte: National Drug Authority

Principio attivo:

DIPHTHERIA TOXOID+TETANUS TOXOID+PERTUSSIS TOXOID(PT)+FILAMENTOUS HAEMAGGLUTININ(FHA)+PERTACTIN(69KDA OMP)+HBSAG PURIFIED,INACTIVATED POLIO VIRUS TYPE I+INACTIVATED POLIO VIRUS TYPE II+INACTIVATED POLIO VIRUS TYPE III+PURIFIED CAPSULAR POLYSACCHARIDE OF HIB COVALENTLY BOUND TO TETANUS TOXOID(PRP-T)

Commercializzato da:

GLAXOSMITHKLINE LTD BELGIUM

INN (Nome Internazionale):

DIPHTHERIA TOXOID+TETANUS TOXOID+PERTUSSIS TOXOID(PT)+FILAMENTOUS HAEMAGGLUTININ(FHA)+PERTACTIN(69KDA OMP)+HBSAG PURIFIED,INACTIVATED POLIO VIRUS TYPE I+INACTIVATED POLIO VIRUS TYPE II+INACTIVATED POLIO VIRUS TYPE III+PURIFIED CAPSULAR POLYSACCHARIDE OF HIB COVALENTLY BOUND TO TETANUS TOXOID(PRP-T)

Dosaggio:

MIN 30 I.U+MIN 40 I.U+25?G+25?G+8?G+10?G,40DU+8DU+32DU+10?G

Forma farmaceutica:

PARENTERAL ORDINARY COMBINATION PACK VIALS

Confezione:

1.0X1.0 PACK CARTON (DTPA-HBV-IPV IN PREFILLED SYRINGE + 2 NEEDLES+FREEZE DRIED HIB IN A VIAL)

Data dell'autorizzazione:

2013-07-01